Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
- Published In:
- Cardiovascular diabetology, 22(1), 126 (2023)
- Authors:
- Schechter, Meir, Melzer Cohen, Cheli, Fishkin, Alisa, Rozenberg, Aliza, Yanuv, Ilan, Sehtman-Shachar, Dvora R, Chodick, Gabriel, Clark, Alice, Abrahamsen, Trine J, Lawson, Jack, Karasik, Avraham, Mosenzon, Ofri
- Database ID:
- RPEP-07352
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07352APA
Schechter, Meir; Melzer Cohen, Cheli; Fishkin, Alisa; Rozenberg, Aliza; Yanuv, Ilan; Sehtman-Shachar, Dvora R; Chodick, Gabriel; Clark, Alice; Abrahamsen, Trine J; Lawson, Jack; Karasik, Avraham; Mosenzon, Ofri. (2023). Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.. Cardiovascular diabetology, 22(1), 126. https://doi.org/10.1186/s12933-023-01829-0
MLA
Schechter, Meir, et al. "Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.." Cardiovascular diabetology, 2023. https://doi.org/10.1186/s12933-023-01829-0
RethinkPeptides
RethinkPeptides Research Database. "Kidney function loss and albuminuria progression with GLP-1 ..." RPEP-07352. Retrieved from https://rethinkpeptides.com/research/schechter-2023-kidney-function-loss-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.